… the developed LC/MS/MS method is well suited to quantify multiple mycotoxin biomarkers
in … The co-occurrence of several mycotoxins in the investigated samples clearly emphasizes …

… Therefore, this was the extraction method of choice for further analysis since the purpose
of this study was to develop a multi-mycotoxin method suitable for large-scale HB. For the …

… To date, biomarkers are used to monitor mycotoxin exposure … The goal of this research was
to develop and validate a … determination of 18 mycotoxin biomarkers, including fumonisins, …

… development of biomarkers of exposure for the assessment of three important mycotoxins: …
A number of different biomarkers and methods have been developed that can be applied to …

… mycotoxins’ roles in the etiology of disease and the effectiveness of mitigation strategies. This
review will discuss mycotoxin biomarker development … mycotoxin biomarker interpretation. …

… mycotoxins ingested and the amount of relevant biomarkers … 0.78 for the tested couples of
mycotoxin/biomarker. The good … permitted to validate the selected mycotoxin biomarkers in …

… Therefore, a novel optimized LLE method, including these two important steps and a wide
range of analytes (35), was developed and validated in this study. To the best of the authors’ …

… mycotoxins in humans is unknown and it is necessary to define the best biomarker/s for
each mycotoxin … is commonly used as a biomarker of exposure to mycotoxins [9], although …

… of mycotoxin biomarker development in humans and animal research for commercially
important mycotoxins. … of biomarkers in animal and human systems is transferable to studies of …

… of mycotoxin biomarkers in urine of humans and animals provides a direct approach for
assessing exposure to these mycotoxins as … Seven (7) mycotoxins and their metabolites (total 18 …